Jeffrey Eisele, Chief Development Officer: Apellis Pharmaceuticals APLS Sell · Filed 23/01/25

Trade details

Type: Insider sale
Amount: $231,026.82
Shares · price: 4,479 sh · $51.58 a share
Held after: 47,718 sh
Stock: Apellis Pharmaceuticals APLS
Person: Jeffrey EiseleChief Development Officer
Trade date: 23/01/23
Filed: 23/01/25
Days to filing: 2 days

Sold 8.6% of holdings

Share of holding sold: 8.6%

Apellis Pharmaceuticals trades, last 26 weeks

What else happened in Apellis Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 22/12/24~23/02/22

Jeffrey Eisele's recent trades

Jeffrey EiseleChief Development Officer
SellApellis Pharmaceuticals
Sell
Apellis Pharmaceuticals
APLS
$8,207
278 sh
$8,207
Filed 25/01/30
Traded 25/01/29
Jeffrey EiseleChief Development Officer
SellApellis Pharmaceuticals
Sell
Apellis Pharmaceuticals
APLS
$39.3K
1,291 sh
$39.3K
Filed 25/01/23
Traded 25/01/22
Jeffrey EiseleChief Development Officer
SellApellis Pharmaceuticals
Sell
Apellis Pharmaceuticals
APLS
$7,577
264 sh
$7,577
Filed 25/01/14
Traded 25/01/13
Jeffrey EiseleChief Development Officer
SellApellis Pharmaceuticals
Sell
Apellis Pharmaceuticals
APLS
$2,085
63 sh
$2,085
Filed 24/12/27
Traded 24/12/23
Jeffrey EiseleChief Development Officer
Sell10b5-1 planApellis Pharmaceuticals
Sell10b5-1 plan
Apellis Pharmaceuticals
APLS
$63.6K
971 sh
$63.6K
Filed 24/01/31
Traded 24/01/30

Jeffrey Eisele, Chief Officer — sold $231K of Apellis Pharmaceuticals APLS · 8.6% of holdings | Whalegun